Edition:
United Kingdom

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

2.11USD
8:39pm BST
Change (% chg)

$-0.01 (-0.47%)
Prev Close
$2.12
Open
$2.16
Day's High
$2.16
Day's Low
$2.09
Volume
2,851
Avg. Vol
16,649
52-wk High
$11.90
52-wk Low
$1.71

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 -0.006
Sep '17 0.00 -0.009
Jun '17 0.00 -0.000
Mar '17 0.00 -0.011
FY 2016 Dec '16 0.00 -0.007
Sep '16 0.00 -0.000
Jun '16 0.00 -0.005
Mar '16 0.00 -0.003
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 10.00 10.00 10.00 0.00
Quarter Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 2 5.00 10.00 0.00 0.00
Year Ending Dec-19 2 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 1 -0.26 -0.26 -0.26 --
Quarter Ending Dec-18 1 -0.23 -0.23 -0.23 --
Year Ending Dec-18 1 -0.90 -0.90 -0.90 -2.41
Year Ending Dec-19 1 -0.83 -0.83 -0.83 -3.22
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.48 32.76
P/E High - Last 5 Yrs. -- 298.85 45.44
P/E Low - Last 5 Yrs. -- 91.59 24.26
Beta -8.40 0.93 0.89
Price to Sales (TTM) -- 112.69 5.73
Price to Book (MRQ) 3.11 14.09 5.45
Price to Tangible Book (MRQ) 3.12 14.67 7.05
Price to Cash Flow (TTM) -- 72.72 23.29
% Owned Institutions 26.54 14.42 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.70 5.22
Payout Ratio(TTM) -- 16.38 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 408.74 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.05 5.64
Sales - 5 Yr. Growth Rate -- 32.09 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 95.07 29.06 20.60
EPS (TTM) vs TTM 1 Yr. Ago 71.70 -- --
EPS - 5 Yr. Growth Rate -- 39.56 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.05 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.92 2.22
Current Ratio (MRQ) 3.48 5.50 3.03
LT Debt to Equity (MRQ) 0.00 25.57 12.39
Total Debt to Equity (MRQ) 0.00 27.28 16.72
Interest Coverage (TTM) -- -101.33 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.25 54.37
Gross Margin - 5 Yr. Avg. -- 50.67 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -588.18 10.81
Operating Margin (TTM) -- -734.89 4.57
Operating Margin - 5 Yr. Avg. -- -609.81 6.23
Pre-Tax Margin (TTM) -- -708.96 5.43
Pre-Tax Margin - 5 Yr. Avg. -- -613.30 6.67
Net Profit Margin (TTM) -- -710.36 1.73
Net Profit Margin - 5 Yr. Avg. -- -616.33 2.94
Effective Tax Rate (TTM) -- 23.27 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.59 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,066,163 860,414,701
Net Income/Employee (TTM) -1,440,585 3,124,085 101,211,889
Receivable Turnover (TTM) -- 20.78 5.87
Inventory Turnover (TTM) -- 2.48 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -48.19 0.33 11.14
Return on Assets - 5 Yr. Avg. -69.68 3.75 12.40
Return on Investment (TTM) -68.01 2.29 14.61
Return on Investment - 5 Yr. Avg. -103.47 2.93 16.14
Return on Equity (TTM) -68.13 3.86 16.34
Return on Equity - 5 Yr. Avg. -105.91 4.40 17.40
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 71.04 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akari Therapeutics PLC

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 10.44%
# of Holders: 12
Total Shares Held: 1,592,103
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.